BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9201008)

  • 1. Use of postmenopausal hormone replacement therapy by African American women. The importance of physician discussion.
    McNagny SE; Jacobson TA
    Arch Intern Med; 1997 Jun; 157(12):1337-42. PubMed ID: 9201008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personal use of postmenopausal hormone replacement therapy by women physicians in the United States.
    McNagny SE; Wenger NK; Frank E
    Ann Intern Med; 1997 Dec; 127(12):1093-6. PubMed ID: 9412312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic differences in hormone replacement prescribing patterns.
    Brown AF; Pérez-Stable EJ; Whitaker EE; Posner SF; Alexander M; Gathe J; Washington AE
    J Gen Intern Med; 1999 Nov; 14(11):663-9. PubMed ID: 10571714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women.
    Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS
    Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in physician recommendation of hormone replacement therapy.
    Weng HH; McBride CM; Bosworth HB; Grambow SC; Siegler IC; Bastian LA
    Prev Med; 2001 Dec; 33(6):668-73. PubMed ID: 11716665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women.
    Shlipak MG; Angeja BG; Go AS; Frederick PD; Canto JG; Grady D
    Circulation; 2001 Nov; 104(19):2300-4. PubMed ID: 11696469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy for African American women: missed opportunities for effective intervention.
    Nicholson WK; Brown AF; Gathe J; Grumbach K; Washington AE; Pérez-Stable EJ
    Menopause; 1999; 6(2):147-55. PubMed ID: 10374222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
    Hou N; Hong S; Wang W; Olopade OI; Dignam JJ; Huo D
    J Natl Cancer Inst; 2013 Sep; 105(18):1365-72. PubMed ID: 24003037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal hormone replacement therapy use by older Mexican-American women.
    Newell DA; Markides KS; Ray LA; Freeman JL
    J Am Geriatr Soc; 2001 Aug; 49(8):1046-51. PubMed ID: 11555065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.
    Connelly MT; Richardson M; Platt R
    J Gen Intern Med; 2000 Aug; 15(8):542-50. PubMed ID: 10940145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The North American Menopause Society 1998 menopause survey: Part II. Counseling about hormone replacement therapy: association with socioeconomic status and access to medical care.
    Ettinger B; Woods NF; Barrett-Connor E; Pressman A
    Menopause; 2000; 7(3):143-8. PubMed ID: 10810958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward hormone replacement therapy in the new millennium: university physicians' and patients' perspectives.
    Ismail HM; Aleveritis E; Guha B; Olive K; Sloan S
    J Investig Med; 2005 Sep; 53(6):305-11. PubMed ID: 16207467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discussion of hormone replacement therapy between physicians and their patients.
    Schneider AE; Davis RB; Phillips RS
    Am J Med Qual; 2000; 15(4):143-7. PubMed ID: 10948786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis medications used by older African-American women: effects of socioeconomic status and psychosocial factors.
    Unson CG; Fortinsky R; Prestwood K; Reisine S
    J Community Health; 2005 Aug; 30(4):281-97. PubMed ID: 15989210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal estrogen use among African American and white patients at an urban clinic.
    Jahnige K; Fiebach N
    J Womens Health; 1997 Feb; 6(1):93-101. PubMed ID: 9065378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and personal relationships between oral contraceptive and hormone replacement therapy use among US women physicians.
    Frank E; Elon L
    Menopause; 2003; 10(2):133-41. PubMed ID: 12627038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HRT management: the American experience.
    Carr BR
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S17-20. PubMed ID: 8732468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of race/ethnicity and social class to hormone replacement therapy: results from the Third National Health and Nutrition Examination Survey 1988-1994.
    Friedman-Koss D; Crespo CJ; Bellantoni MF; Andersen RE
    Menopause; 2002; 9(4):264-72. PubMed ID: 12082362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The perceptions of menopause of African-American and white women and affect on willingness to participate in a HRT clinical trial.
    Strickland OL; Dunbar SB
    J Natl Black Nurses Assoc; 2000 Jan; 11(1):43-50. PubMed ID: 11854952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women.
    Angeja BG; Shlipak MG; Go AS; Johnston SC; Frederick PD; Canto JG; Barron HV; Grady D;
    J Am Coll Cardiol; 2001 Nov; 38(5):1297-301. PubMed ID: 11691498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.